Small Lymphocytic Lymphoma and Chronic Lymphocytic Leukemia
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference89 articles.
1. . Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.;Hallek;Blood,2008
2. . Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.;Dores;Br J Haematol,2007
3. . Small lymphocytic lymphoma.;Morrison;J Clin Oncol,1989
4. New approach to classifying non-Hodgkins lymphomas: clinical features of the major histologic subtypes. Non-Hodgkins Lymphoma Classification Project.;Armitage;J Clin Oncol,1998
5. . Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center.;Tsimberidou;J Clin Oncol,2007
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Case Study;Journal of Diagnostic Medical Sonography;2023-12-14
2. Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma;Journal of Chemotherapy;2023-12-11
3. Real‐world management of small lymphocytic lymphoma as chronic lymphocytic leukaemia versus an indolent non‐Hodgkin lymphoma;British Journal of Haematology;2023-05-25
4. A real‐world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first‐line (1L) treatment for patients with chronic lymphocytic leukaemia (CLL) in the United States;eJHaem;2023-01-23
5. Evaluating orelabrutinib as a novel treatment option for relapsed/refractory chronic lymphocytic leukemia in China;Expert Opinion on Pharmacotherapy;2022-11-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3